Four new assays for cytokine research

Arrays designed to measure cytokine responses of different sides of the immune system Logan, UT, April 25th, 2022 – Quansys Biosciences releases four new assays to measure cytokine responses of the human immune system. Each array is designed to measure cytokine...

Human SARS-CoV-2 IgG (5-plex) to measure antibodies against nucleocapsid

Quansys Biosciences releases multiplex assay to measure antibodies from vaccination and from natural infection Logan, UT, July 28, 2021 – Quansys Biosciences in Logan, Utah, has recently released their Q-Plex™ Human SARS-CoV-2 IgG (5-plex) multiplex ELISA to...

FDA EUA for SARS-CoV-2 IgG Antibody Test

For Immediate Release Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance Lede: Quansys Biosciences to release the first multiplexed serological assay for SARS-CoV-2 to be...

Human Serological SARS-CoV-2 (4-Plex) ELISA

For Immediate Release Quansys Biosciences Releases Multiplex Human Serological SARS-CoV-2 (4-plex) ELISA Lede: Quansys Biosciences to release the first multiplexed serological assay for SARS-CoV-2 to be used in surveillance studies. Logan, UT, April 8, 2020 — Quansys...

Quansys to present at Biomarkers & World CDx Conference

For Immediate Release Contact: scall@quansysbio.com Quansys to present on multiplexing protein biomarkers in Precision Medicine at the 10th Annual, Clinical, Biomarkers & World CDx Conference Logan, UT, August 22, 2019—Quansys Biosciences, Inc. a pioneer in...